Phenoxyethyl piperidine compounds
US-9402838-B2 · Aug 2, 2016 · US
Phenoxyethyl cyclic amine derivatives and their activity as EP4 receptor modulators
US9776964B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9776964-B2 |
| Application number | US-201415030888-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 11, 2014 |
| Priority date | Dec 17, 2013 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a compound of the Formula (I): wherein X, R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are as defined herein, or a pharmaceutically acceptable salt thereof.
First claim
Opening claim text (preview).
We claim: 1. A compound of the formula: wherein X is: R is H, methyl, or ethyl; R 1 is methyl, when R 2 is H, and R 1 is H when R 2 is methyl; R 3 is H or F; R 4 is H, F, or methyl; R 5 is OH, methyl, methoxy, or F; and R 6 is H when R 7 is OH, and R 6 is F when R 7 is F; or a pharmaceutically acceptable salt thereof. 2. The compound or salt according to claim 1 wherein R is methyl. 3. The compound or salt according to claim 2 wherein R 4 is F and R 5 is F. 4. The compound or salt according to claim 2 wherein R 4 is methyl and R 5 is methyl. 5. The compound or salt according to claim 1 wherein X is: 6. The compound or salt according to claim 1 wherein X is: 7. A pharmaceutical composition, comprising a compound or a pharmaceutically acceptable salt thereof according to claim 1 with one or more pharmaceutically acceptable carriers, diluents, or excipients.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen · CPC title
- C07D211/60Primary
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9776964B2 cover?
- The present invention provides a compound of the Formula (I): wherein X, R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are as defined herein, or a pharmaceutically acceptable salt thereof.
- Who is the assignee on this patent?
- Lilly Co Eli
- What technology area does this patent fall under?
- Primary CPC classification C07D211/60. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).